| 2020 |
Prideaux M, Kitase Y, Kimble M, O'Connell TM, Bonewald LF. Taurine, an osteocyte metabolite, protects against oxidative stress-induced cell death and decreases inhibitors of the Wnt/β-catenin signaling pathway. Bone. August 2020;137:115374. |
0 |
0 |
| 2021 |
Tippen SP, Noonan ML, Ni P, Metzger CE, Swallow EA, Sacks SA, Chen NX, Thompson WR, Prideaux M, Atkins GJ, Moe SM, Allen MR, White KE. Age and sex effects on FGF23-mediated response to mild phosphate challenge. Bone. May 2021;146:115885. |
3 |
2 |
| 2023 |
Kitase Y, Prideaux M. Targeting osteocytes vs osteoblasts. Bone. May 2023;170:116724. |
2 |
2 |
| 2013 |
Dallas SL, Prideaux M, Bonewald LF. The osteocyte: an endocrine cell … and more. Endocr Rev. October 2013;34(4):658-690. |
53 |
50 |
| 2021 |
Noonan ML, Ni P, Agoro R, Sacks SA, Swallow EA, Wheeler JA, Clinkenbeard EL, Capitano ML, Prideaux M, Atkins GJ, Thompson WR, Allen MR, Broxmeyer HE, White KE. The HIF-PHI BAY 85-3934 (Molidustat) improves anemia and is associated with reduced levels of circulating FGF23 in a CKD mouse model. J Bone Miner Res. June 2021;36(6):1117-1130. |
0 |
0 |
| 2023 |
Kittaka M, Yoshimoto T, Levitan ME, Urata R, Choi RB, Teno Y, Xie Y, Kitase Y, Prideaux M, Dallas SL, Robling AG, Ueki Y. Osteocyte RANKL drives bone resorption in mouse ligature-induced periodontitis. J Bone Miner Res. October 2023;38(10):1521-1540. |
0 |
0 |